![Fresenius Kabi Announces Availability of Fulvestrant Injection 250mg per 5mL prefilled syringe | Business Wire Fresenius Kabi Announces Availability of Fulvestrant Injection 250mg per 5mL prefilled syringe | Business Wire](https://mms.businesswire.com/media/20191007005077/en/747937/5/Fulvestrant_Carton_and_Syringes_Photo.jpg)
Fresenius Kabi Announces Availability of Fulvestrant Injection 250mg per 5mL prefilled syringe | Business Wire
![Pharmacokinetic profile of the fulvestrant loading dose regimen in postmenopausal women with hormone receptor-positive advanced breast cancer. | Semantic Scholar Pharmacokinetic profile of the fulvestrant loading dose regimen in postmenopausal women with hormone receptor-positive advanced breast cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d64fa7dd85a27501cb846824494db80e816e7919/4-Table2-1.png)
Pharmacokinetic profile of the fulvestrant loading dose regimen in postmenopausal women with hormone receptor-positive advanced breast cancer. | Semantic Scholar
![Three dose regimens of fulvestrant in postmenopausal Japanese women with advanced breast cancer: results from a double-blind, phase II comparative study (FINDER1) - ScienceDirect Three dose regimens of fulvestrant in postmenopausal Japanese women with advanced breast cancer: results from a double-blind, phase II comparative study (FINDER1) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419392555-gr2.jpg)
Three dose regimens of fulvestrant in postmenopausal Japanese women with advanced breast cancer: results from a double-blind, phase II comparative study (FINDER1) - ScienceDirect
![Faslodex® (fulvestrant) in the treatment of metastatic breast cancer Prescribing information is available on the last slide March ppt video online download Faslodex® (fulvestrant) in the treatment of metastatic breast cancer Prescribing information is available on the last slide March ppt video online download](https://slideplayer.com/slide/6205080/18/images/3/Faslodex+indication.jpg)
Faslodex® (fulvestrant) in the treatment of metastatic breast cancer Prescribing information is available on the last slide March ppt video online download
![These highlights do not include all the information needed to use FASLODEX safely and effectively. See full prescribing information for FASLODEX. FASLODEX® (fulvestrant) injection, for intramuscular useInitial U.S. Approval: 2002 These highlights do not include all the information needed to use FASLODEX safely and effectively. See full prescribing information for FASLODEX. FASLODEX® (fulvestrant) injection, for intramuscular useInitial U.S. Approval: 2002](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=NDC0310-0720-10.jpg&id=662856)